Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,879,430
+$762,631 QoQ
Shares Held
111,953
+1.5% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 290 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. DNLI ranks #63 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in DNLI
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,879,430 | 111,953 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,116,799 | 110,250 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,166,490 | 131,223 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $2,090,182 | 143,952 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,843,250 | 131,755 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,065,923 | 151,962 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,047,074 | 149,513 | Shares | Defined | 2025-02-13 | |
| 2024-06-30 | $3,003,413 | 129,346 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $2,290,060 | 106,713 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $2,183,168 | 105,825 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,095,362 | 104,892 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,249,118 | 97,618 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,642,366 | 95,015 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,639,860 | 86,017 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,545,782 | 86,503 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $2,555,133 | 79,426 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,522,106 | 78,971 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,911,286 | 77,528 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,882,418 | 62,244 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,486,703 | 43,550 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,760,572 | 44,897 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,418,366 | 39,586 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $840,350 | 34,754 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $460,127 | 26,278 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||